Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Synthesis and structure-activity studies of antibacterial oxazolidinones containing dihydrothiopyran or dihydrothiazine C-rings.

Renslo AR, Luehr GW, Lam S, Westlund NE, Gómez M, Hackbarth CJ, Patel DV, Gordeev MF.

Bioorg Med Chem Lett. 2006 Jul 1;16(13):3475-8. Epub 2006 Apr 27.

PMID:
16644216
2.

New antibacterial tetrahydro-4(2H)-thiopyran and thiomorpholine S-oxide and S,S-dioxide phenyloxazolidinones.

Singh U, Raju B, Lam S, Zhou J, Gadwood RC, Ford CW, Zurenko GE, Schaadt RD, Morin SE, Adams WJ, Friis JM, Courtney M, Palandra J, Hackbarth CJ, Lopez S, Wu C, Mortell KH, Trias J, Yuan Z, Patel DV, Gordeev MF.

Bioorg Med Chem Lett. 2003 Dec 1;13(23):4209-12.

PMID:
14623003
3.

N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity.

Hackbarth CJ, Chen DZ, Lewis JG, Clark K, Mangold JB, Cramer JA, Margolis PS, Wang W, Koehn J, Wu C, Lopez S, Withers G 3rd, Gu H, Dunn E, Kulathila R, Pan SH, Porter WL, Jacobs J, Trias J, Patel DV, Weidmann B, White RJ, Yuan Z.

Antimicrob Agents Chemother. 2002 Sep;46(9):2752-64.

4.

A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci.

Zhang HZ, Hackbarth CJ, Chansky KM, Chambers HF.

Science. 2001 Mar 9;291(5510):1962-5.

5.

Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene.

Margolis PS, Hackbarth CJ, Young DC, Wang W, Chen D, Yuan Z, White R, Trias J.

Antimicrob Agents Chemother. 2000 Jul;44(7):1825-31.

6.

Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.

Chen DZ, Patel DV, Hackbarth CJ, Wang W, Dreyer G, Young DC, Margolis PS, Wu C, Ni ZJ, Trias J, White RJ, Yuan Z.

Biochemistry. 2000 Feb 15;39(6):1256-62.

PMID:
10684604
8.

Cloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37Ra.

Hackbarth CJ, Unsal I, Chambers HF.

Antimicrob Agents Chemother. 1997 May;41(5):1182-5.

9.

Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.

Kocagöz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF.

Antimicrob Agents Chemother. 1996 Aug;40(8):1768-74.

10.

Point mutations in Staphylococcus aureus PBP 2 gene affect penicillin-binding kinetics and are associated with resistance.

Hackbarth CJ, Kocagoz T, Kocagoz S, Chambers HF.

Antimicrob Agents Chemother. 1995 Jan;39(1):103-6.

11.
12.

Kinetics of penicillin binding to penicillin-binding proteins of Staphylococcus aureus.

Chambers HF, Sachdeva MJ, Hackbarth CJ.

Biochem J. 1994 Jul 1;301 ( Pt 1):139-44.

13.
14.

Methicillin-resistant staphylococci: detection methods and treatment of infections.

Hackbarth CJ, Chambers HF.

Antimicrob Agents Chemother. 1989 Jul;33(7):995-9. Review. No abstract available.

15.

Methicillin-resistant staphylococci: genetics and mechanisms of resistance.

Hackbarth CJ, Chambers HF.

Antimicrob Agents Chemother. 1989 Jul;33(7):991-4. Review. No abstract available.

16.

Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia.

Kapusnik JE, Hackbarth CJ, Chambers HF, Carpenter T, Sande MA.

J Infect Dis. 1988 Jul;158(1):7-12. Erratum in: J Infect Dis 1988 Oct;158(4):911.

PMID:
3392422
18.

The influence of fever on the development of experimental Streptococcus pneumoniae meningitis.

Sande MA, Sande ER, Woolwine JD, Hackbarth CJ, Small PM.

J Infect Dis. 1987 Nov;156(5):849-50. No abstract available.

PMID:
3655405
19.

Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits.

Täuber MG, Shibl AM, Hackbarth CJ, Larrick JW, Sande MA.

J Infect Dis. 1987 Sep;156(3):456-62.

PMID:
3302052
20.

Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits.

Hackbarth CJ, Chambers HF, Stella F, Shibl AM, Sande MA.

J Antimicrob Chemother. 1986 Nov;18 Suppl D:65-9.

PMID:
3100492
21.

Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.

Carpenter TC, Hackbarth CJ, Chambers HF, Sande MA.

Antimicrob Agents Chemother. 1986 Sep;30(3):382-4.

22.

Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits.

Small PM, Täuber MG, Hackbarth CJ, Sande MA.

Infect Immun. 1986 May;52(2):484-7.

23.

Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus.

Hackbarth CJ, Chambers HF, Sande MA.

Antimicrob Agents Chemother. 1986 Apr;29(4):611-3.

24.

Evaluation of pefloxacin in experimental Escherichia coli meningitis.

Shibl AM, Hackbarth CJ, Sande MA.

Antimicrob Agents Chemother. 1986 Mar;29(3):409-11.

25.

Serum bactericidal titer as a predictor of outcome in endocarditis.

Hackbarth CJ, Chambers HF, Sande MA.

Eur J Clin Microbiol. 1986 Feb;5(1):93-7.

PMID:
2938947
26.

Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.

Sullam PM, Täuber MG, Hackbarth CJ, Chambers HF, Scott KG, Sande MA.

Antimicrob Agents Chemother. 1985 May;27(5):685-7.

27.

Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.

Gordin FM, Hackbarth CJ, Scott KG, Sande MA.

Antimicrob Agents Chemother. 1985 Apr;27(4):452-4.

28.

Influence of the developmental state of valvular lesions on the antimicrobial activity of cefotaxime in experimental enterococcal infections.

Sullam PM, Drake TA, Täuber MG, Hackbarth CJ, Sande MA.

Antimicrob Agents Chemother. 1985 Mar;27(3):320-3.

29.

New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.

Täuber MG, Hackbarth CJ, Scott KG, Rusnak MG, Sande MA.

Antimicrob Agents Chemother. 1985 Mar;27(3):340-2.

30.

Antimicrobial activity of gentamicin in experimental enterococcal endocarditis.

Sullam PM, Täuber MG, Hackbarth CJ, Sande MA.

Antimicrob Agents Chemother. 1985 Feb;27(2):224-6.

31.

Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis.

Sullam PM, Täuber MG, Hackbarth CJ, Sande MA.

Antimicrob Agents Chemother. 1985 Jan;27(1):135-6.

32.

Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.

Chambers HF, Hackbarth CJ, Drake TA, Rusnak MG, Sande MA.

J Infect Dis. 1984 Jun;149(6):894-903.

PMID:
6564133
33.

Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.

Rusnak MG, Drake TA, Hackbarth CJ, Sande MA.

J Infect Dis. 1984 Jun;149(6):980-5.

PMID:
6429255
34.

Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae.

Täuber MG, Doroshow CA, Hackbarth CJ, Rusnak MG, Drake TA, Sande MA.

J Infect Dis. 1984 Apr;149(4):568-74.

PMID:
6327835
35.

Value of serum tests in combined drug therapy of endocarditis.

Drake TA, Hackbarth CJ, Sande MA.

Antimicrob Agents Chemother. 1983 Nov;24(5):653-7.

36.

Inhibition of isolation of Escherichia coli in blood cultures by trimethoprim-sulfamethoxazole.

Hackbarth CJ, Ernst JD, Sande MA.

J Infect Dis. 1983 May;147(5):964-5. No abstract available.

PMID:
6341486

Supplemental Content

Loading ...
Support Center